Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 24, 2021

Novartis Vaccines and Diagnostics, Inc. et al v. Genentech, Inc.

Track this case

Case Number:

3:21-cv-04874

See also:

Court:

California Northern

Nature of Suit:

Patent

Judge:

Joseph C. Spero

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 25, 2021

    Novartis Says Genentech Won't Return $210M IP Overpayment

    Genentech improperly failed to alert Novartis Pharma AG that it was overpaying tens of millions of dollars on a patent licensing deal, then refused to return more than $209.5 million in excess payments, Novartis alleged in a complaint removed to California federal court Thursday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login